Skip to main content
Clinical Trials/ACTRN12622000017729
ACTRN12622000017729
Active, not recruiting
未知

Feasibility Study for A Medtronic Next Generation Hybrid Closed Loop System in adults with Type 1 diabetes

St Vincent's Hospital Melbourne0 sites22 target enrollmentJanuary 11, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
Type 1 Diabetes
Sponsor
St Vincent's Hospital Melbourne
Enrollment
22
Status
Active, not recruiting
Last Updated
4 years ago

Overview

Brief Summary

Results TBD

Registry
who.int
Start Date
January 11, 2022
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
St Vincent's Hospital Melbourne

Eligibility Criteria

Inclusion Criteria

  • Age greater than or equal to 18 years; T1D of \>1 year duration; stable on insulin pump therapy for \>3 months; proficient in carbohydrate counting; continuous glucose monitoring (CGM) sensor experience; HbA1c \<10\.0%.
  • Participants must have enrolled in a previously registered study in order to participate in this study (ACTRN12620000687998\).

Exclusion Criteria

  • Pregnancy; eGFR\<40; a history of diabetic ketoacidosis in the last 3 months; diabetic gastroparesis; tape allergy; unable to exercise; major medical or psychiatric illness.

Outcomes

Primary Outcomes

Not specified

Similar Trials